Items where authors include "Shepherd, L"

Article

Abani, O, Abbas, A, Abbas, F et al. (6300 more authors) (2022) Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 399 (10325). pp. 665-676. ISSN 0140-6736

Abani, O orcid.org/0000-0003-2209-9956, Abbas, A, Abbas, F et al. (6346 more authors) (2021) Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 397 (10285). pp. 1637-1645. ISSN 0140-6736

Gray, R, Bradley, R, Braybrooke, J et al. (164 more authors) (2019) Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-analysis of 37 298 women with early breast cancer in 26 randomised trials. The Lancet, 393 (10179). pp. 1440-1452. ISSN 0140-6736

Proceedings Paper

Spears, M, Kalatskaya, I, Trinh, QM et al. (12 more authors) (2018) Targeted sequencing in early breast cancer: Identification of novel candidate mutations predictive of anthracycline benefit. In: Cancer Research. 2017 San Antonio Breast Cancer Symposium, 05-09 Dec 2017, San Antonio, Texas, U.S.A.. American Association for Cancer Research .

Spears, M, Kornaga, E, Lyttle, N et al. (12 more authors) (2018) Validation that a histone gene signature predicts anthracycline response in early breast cancer. In: Cancer Research. 2017 San Antonio Breast Cancer Symposium, 05-09 Dec 2017, San Antonio, Texas, U.S.A.. American Association for Cancer Research. American Association for Cancer Research .